Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
163
NCT01068509
Ovarian Cancer Vaccine for Patients in Remission
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2010
Completion: Apr 30, 2015
NCT01617629
Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study
Start: Dec 31, 2011
Completion: Apr 30, 2014
NCT01521143
Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment
Start: Jan 31, 2012
Completion: Mar 31, 2015
NCT02310971
Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
Start: Feb 28, 2015